Evaluation and nonsurgical management of erectile dysfunction

Urologic Clinics of North America

Volumn 25, Issue 4, 1998, Pages 647-659

  Sharlip, I D ^a  

^a c/o Pan Pacific Urology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; PROSTAVASIN; SILDENAFIL; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; VASOACTIVE AGENT; YOHIMBINE;

CAVERNOSOGRAPHY; CLINICAL TRIAL; COLOR BLINDNESS; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; DRUG SELF ADMINISTRATION; ELECTROMYOGRAPHY; ENDOCRINE FUNCTION TEST; FIBROSIS; GASTROINTESTINAL SYMPTOM; HEADACHE AND FACIAL PAIN; HORMONAL THERAPY; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAURETHRAL DRUG ADMINISTRATION; LABORATORY TEST; LIVER TOXICITY; MALE; NEUROPSYCHOLOGICAL TEST; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PAIN; PRIORITY JOURNAL; PSYCHOMETRY; RADIOGRAPHY; REVIEW; SEXUAL DYSFUNCTION; SUBLINGUAL DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0031733870     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70054-9     Document Type: Article

References (39)

1. S. Arver A.S. Dobbs A.W. Meikle Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system J Urol 155 1996 1604
2. E. Becher M. Borghi A. Momessa Penile hemodynamic findings with a new topical formulation of Alprostadil (abstract no. 915) J Urol 159 suppl 1998 239
3. Goldstein I. Vasomax Study Group Efficacy and Safety of Oral phentolamine (Vasomax) for the treatment of minimal erectile dysfunction (abstract no. 919) J Urol 159 suppl 1998 240
4. B.L.H. Bemelmans L.B.P.M. Hendrikx E.L. Koldewijn Comparison of biothesiometry and neurourophysiological investigations for the clinical evaluation of patients with erectile dysfunction J Urol 153 1995 1483
5. B.L.H. Bemelmans E.J.H. Meulemann W.H. Dosburg Erectile dysfunction in diabetic men: The neurological factor revisited J Urol 151 1994 884
6. M. Boolell M.J. Allen S.A. Ballard An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erection dysfunction Int J Impot Res 8 1996 47
7. J. Buvat C.J. Gingell A. Jardin Sildenafil (Viagra), an oral treatment for erectile dysfunction: A 1-yr open-label, extension study [abstract no. 793] J Urol 157 suppl 1997 204
8. J. Buvat A. Lemaire Endocrine screening in 1022 men with erectile dysfunction: Clinical significance and cost-effective strategy J Urol 158 1997 1764
9. P. Costa B. Sarrazin F. Bressolle Efficacy and side-effects of intracavernous injections of moxisylyte in impotent patients: A dose frequency study versus placebo J Urol 149 1993 301
10. M. Fabra A. Frieling H. Porst Single potential analysis of corpus cavernosum electromyography for the assessment of erectile dysfunction: Provocation, reproducibility and age dependent finding in 36 healthy volunteers and 324 patients J Urol 158 1997 444
11. I. Goldstein T.F. Lue H. Padma-Nathan Oral sidenafil in the treatment of erectile dysfunction N Engl J Med 338 1998 1397 1401
12. Padma-Nathan H. Fromm-Freecks D.D. Ruff Efficacy and safety of Apomorphine SL vs. placebo for male erectile dysfunction (MED) (abstract no. 930) J Urol 159 suppl 1998 239
13. J.P. Jarow P. Nana-Sinkham M. Sabbagh Outcome analysis of goal-directed therapy for impotence J Urol 155 1996 1609
14. E.D. Kim R. El-Rashidy K.T. McVary Papaverine topical gel for treatment of erectile dysfunction J Urol 153 1995 361
15. 1 for the treatment of erectile dysfunction J Urol 153 1995 1828
16. R.F. Kropman R.J. Tegelaar A.H. Zwinderman Analysis of continuous nocturnal penile rigidity measurements with the use of the Rigiscan summary analysis software program Int J Impot Res 7 1995 71
17. 1 and visual sexual stimulation J Urol 149 1993 49
18. F.A. Levine E.L. Lenting Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction Urol Clin North Am 22 1995 775
19. O.I. Linet F.G. Ogrinc Efficacy and safety of intracavernous alprostadil in men with erectile dysfunction N Engl J Med 334 1996 873
20. T.F. Lue Impotence: A patient's goal-directed approach to treatment World J Urol 8 1990 67
21. Lue T.F. Sildenafil Study Group A study of sildenafil (Viagra), a new oral agent for the treatment of male erectile dysfunction [abstract no. 701] J Urol 157 suppl 1997 181
22. C.G. McMahon A pilot study of the role of intracavernous injection of vasoactive intestinal polypeptide (VIP) and phentolomine mesylate in the treatment of erectile dysfunction Int J Impot Res 8 1996 233
23. K.T. McVary S. Polepalle S. Riggi Topical SEPA/PGE-1 gel for the treatment of erectile dysfunction (abstract no. 914) J Urol 159 suppl 1998 239
24. E.J.H. Meulemann B.L.H. Bemelmans vanAsten W.N.J.C. Assessment of penile blood flow by duplex ultrasonography in 44 men with normal erectile potency in different phases of erection J Urol 147 1992 51
25. D.K. Montague J.H. Barada A.M. Belker Clinical guidelines panel on erectile dysfunction: Summary report on the treatment of organic erectile dysfunction J Urol 156 1996 2007
26. C.P. Oates R.S. Pickard P.H. Powell The use of duplex ultrasound in the assessment of arterial supply to the penis in vasculogenic impotence J Urol 153 1995 354
27. H. Padma-Nathan Evaluation of the corporal veno-occlusive mechanism: Dynamic infusion cavernosometry and cavernosography Semin Interv Radiol 6 1989 71
28. H. Padma-Nathan W.J.G. Hellstrom F.E. Kaiser Treatment of men with erectile dysfunction with transurethral Alprostadil N Engl J Med 336 1997 1
29. E.S. Pescatori D.G. Hatzichristou S. Namburi A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: A hemodynamic study J Urol 151 1994 1209
30. 1 in erectile failure: A survey of world wide experience J Urol 155 1996 8025
31. R.C. Rosen A. Riley G. Wagner The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822
32. J. Roy R.L. Petrone A.H. Agha A double blind placebo-controlled trial of the hemodynamic effects of topical applications of the penis of an aqueous nitroglycerin gel in healthy male volunteers [abstract no. 742] J Urol 155 suppl 1996 496A
33. F. Sasso C.G. Steif G. Gulino Progress in corpus cavernosum electromyography (CC-EMG): Third international workshop on corpus cavernosum electromyography (CC-EMG) Int J Impot Res 9 1997 43
34. A.A. Sidi F. Bechere G. Zhang Patient acceptance of and satisfaction with an external negative pressure device for impotence J Urol 144 1990 1154
35. R. Valdevenito A. Melman Intracavernous self-injection pharmacotherapy program: Analysis of results and complications Int J Impot Res 6 1994 81
36. R. Virag Intracavernous injection of papaverine for erectile failure Lancet 2 1982 398
37. M.D. Wasserman C.P. Pollack A.J. Spielman Theoretical and technical problems in the measurement of nocturnal penile tumescence for the differential diagnosis of impotence Psychol Med 42 1980 575
38. 1 (LLPG1) for intraurethral delivery to treat erectile dysfunction Program Book of 2nd Annual International Symposium September 6, 1997 The Pharmacologic Management of Male Sexual Dysfunction Los Angeles, CA
39. R. Witherington Vacuum constriction device for management of impotence J Urol 141 1988 320